Erratum: Therapeutic targeting of ATP7B in ovarian carcinoma (Clinical Cancer Research (2009) 15 (3770-3780) DOI: 10.1158/1078-0432.CCR-08-2306)

Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt, Erik S. Leshane, Jyotsna B. Halder, Guillermo N. Armaiz-Pena, Whitney A. Spannuth, Takemi Tanaka, Mian M.K. Shahzad, Yvonne G. Lin, Alpa M. Nick, Christopher G. Danes, Jeong Won Lee, Nicholas B. Jennings, Pablo E. Vivas-Mejia, Judith K. Wolf, Robert L. Coleman, Zahid H. Siddik, Gabriel Lopez-Berestein, Svetlana LutsenkoAnil K. Sood

Research output: Contribution to journalComment/debatepeer-review

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 5A, the representative images for “empty liposome” and “control siRNA-DOPC” were both from the “empty liposome” group. MD Anderson’s Office of Research Oversight and Integrity evaluated this error and the original data from the authors; while the Office concluded it had no concerns regarding this publication, it recommended correction of the scientific record. The authors apologize for this error.

Original languageEnglish (US)
Pages (from-to)4454
Number of pages1
JournalClinical Cancer Research
Volume27
Issue number15
DOIs
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: Therapeutic targeting of ATP7B in ovarian carcinoma (Clinical Cancer Research (2009) 15 (3770-3780) DOI: 10.1158/1078-0432.CCR-08-2306)'. Together they form a unique fingerprint.

Cite this